Study Summary
This trial is testing whether using ICG to measure blood flow during surgery can help reduce the incidence of fistulas.
- Surgery Site Fistula
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: Collected at times week 1, 3 months, 6 months, and 12 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control
1 of 2
ICG
1 of 2
Active Control
Experimental Treatment
70 Total Participants · 2 Treatment Groups
Primary Treatment: ICG dye · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is enrollment for this research endeavor currently ongoing?
"As indicated on clinicaltrials.gov, recruitment for this study is ongoing and has been since 11/11/2021 (last edited 5/30/2022)." - Anonymous Online Contributor
How many individuals have committed to participating in this experiment?
"Affirmative, information available on clinicaltrials.gov shows that this medical trial is currently seeking participants; it was initially posted in November of 2021 and last updated May 30th 2022. Seventy patients are needed from a single location." - Anonymous Online Contributor
What adverse effects could be caused by the introduction of ICG dye to a patient's system?
"The safety of ICG dye was rated a 2, as there is some evidence that it can function safely in clinical trials but no data demonstrating its efficacy." - Anonymous Online Contributor